The story of Viagra, and its developer copyright, presents a challenging case study for investors. At first a blockbuster drug, yielding billions in revenue , its exclusivity period created a wave of generic https://sirketlist.com/story23203040/sildenafil-and-the-pharmaceutical-sector-a-uncertain-investment